This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of upper limb, including shoulder
CD2_INSITU_MELANOMA_UPPERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of upper limb, including shoulder
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 223 | 131 | 92 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 68.34 | 66.98 | 70.27 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
273.2
190
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
558.0
147.0
129
7
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
+∞
50.3
46
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
29.7
49.0
67
34
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.2
42.4
73
70
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
129.7
39.5
41
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
162.2
38.3
39
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
26.7
38.0
53
27
L57.0
ICD-10 Finland
Actinic keratosis
11.7
34.3
69
88
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
20.0
33.3
51
34
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
22.3
30.7
45
26
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
19.8
30.1
46
30
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
26.7
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.6
24
*
TQW99
NOMESCO Finland
Other minor procedure on skin
18.1
23.7
37
25
ZZR00
NOMESCO Finland
Flap of skin
47.6
21.0
25
6
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
28.5
18.8
25
10
S18
ICPC
Laceration/cut
3.9
18.1
113
513
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.0
17
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
16.9
16
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.2
16.9
59
152
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
15.8
15
*
S77
ICPC
Malignant neoplasm of skin
+∞
15.8
15
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
41.9
15.7
19
5
SPAT1153
SPAT
Removal of sutures
3.5
13.9
89
383
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
13.7
13
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
+∞
13.7
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
150.2
13.6
14
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
16.7
13.5
21
14
S82
ICPC
Naevus/mole
4.8
13.1
47
122
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
12.6
12
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
138.7
12.6
13
*
D06BB10
ATC
imiquimod; topical
10.7
12.1
23
24
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
11.6
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
11.6
11
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
11.6
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.6
11
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
21.7
11.3
16
8
ZXC50
NOMESCO Finland
Cryotherapy
13.0
11.1
19
16
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
63.6
10.7
12
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
15.4
10.7
17
12
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
116.1
10.5
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
10.5
10
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
9.4
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.4
9
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
9.4
9
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.3
9.3
51
188
XX3DW
NOMESCO Finland
Time consuming IT work
7.5
9.1
21
31
H02AB02
ATC
dexamethasone; systemic
38.7
9.1
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.0
8.8
14
10
ZXC15
NOMESCO Finland
Use of photodynamic technique
52.4
8.8
10
*
ZXC20
NOMESCO Finland
Use of chemical agents
29.0
8.6
11
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
8.4
8
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
8.4
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
19.3
7.7
11
6
ZZA50
NOMESCO Finland
Full thickness skin graft
83.2
7.5
8
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
83.2
7.5
8
*
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
+∞
7.3
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
16.6
7.3
11
7
XQ845
NOMESCO Finland
Dermatoscopy
21.0
7.2
10
5
ZZA00
NOMESCO Finland
Split skin graft
9.3
7.2
14
16
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
6.9
56
261
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
17.5
6.8
10
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
23.5
6.7
9
*
WX110
NOMESCO Finland
Local anesthesy
2.3
6.7
133
957
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.8
6.4
20
45
D22.0
ICD-10 Finland
Melanocytic naevi of lip
+∞
6.3
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
XQ848
NOMESCO Finland
Dermatological photography
9.1
6.2
12
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
135
864
2.43
9.37
6.1
5.1
1.2
1.2
mmol/l
0.38
112
742
125
795
2.30
8.51
6.1
4.6
1.2
1.2
mmol/l
0.46
111
715
97
576
2.21
7.57
4.0
2.1
2.3
2.4
mmol/l
0.50
74
482
110
738
1.97
5.77
2.7
2.3
85.4
77.9
nmol/l
1.96
88
649
110
748
1.93
5.46
4.2
3.5
—
—
—
0
0
13
30
4.54
5.37
2.2
1.3
—
—
—
0
0
47
236
2.26
5.31
4.8
2.6
0.8
0.8
mmol/l
0.32
40
220
33
143
2.53
5.15
2.6
3.5
84.2
82.4
ng/l
0.06
21
123
127
940
1.82
4.53
8.4
6.3
4.0
4.2
e9/l
0.42
102
820
198
1708
2.42
4.36
18.0
11.4
77.0
76.3
ml/min/173m2
0.17
177
1366
10
22
4.71
4.35
1.1
1.5
—
—
—
0
0
165
1346
1.87
4.05
8.6
5.1
74.2
75.9
u/l
0.30
150
1235
166
1365
1.85
3.87
4.7
4.0
11.4
12.3
mm/h
0.34
147
1245
102
733
1.72
3.83
5.0
3.2
35.2
35.5
g/l
0.24
90
685
184
1582
1.93
3.48
19.0
14.0
39.3
39.6
%
0.15
125
1075
72
480
1.74
3.47
1.6
1.5
24.0
21.8
nmol/l
0.40
55
410
51
308
1.85
3.41
3.7
2.7
0.8
0.8
ug/l
0.09
33
206
11
34
3.35
3.10
2.1
1.3
—
—
—
0
0
41
240
1.87
3.01
5.4
4.8
34.2
32.2
%
0.45
19
154
113
884
1.56
2.75
6.8
3.6
10.0
11.5
umol/l
2.03
105
826
9
24
3.86
2.70
1.4
1.3
—
—
—
0
0
56
372
1.67
2.67
3.4
1.9
—
—
—
0
0
209
1924
2.37
2.63
12.5
8.7
24.9
24.4
u/l
0.20
197
1839
197
1784
1.89
2.46
5.1
4.7
1.5
1.5
mmol/l
0.18
162
1638
202
1845
2.01
2.44
5.5
5.3
2.7
2.7
mmol/l
0.19
170
1698
104
814
1.52
2.44
2.2
2.0
90.3
94.7
pmol/l
0.34
46
388
198
1797
1.91
2.44
16.6
12.3
20.3
21.7
mg/l
0.20
167
1387
192
1727
1.80
2.43
6.4
6.3
38.8
40.3
mmol/mol
2.26
162
1604
8
22
3.73
2.38
2.0
1.2
—
—
—
0
0
5
8
6.36
2.38
2.0
1.0
—
—
—
0
0
5
8
6.36
2.38
1.0
1.1
19.6
17.3
u/l
—
5
8
198
1802
1.88
2.34
4.9
4.7
4.7
4.6
mmol/l
0.47
166
1660
188
1686
1.73
2.34
6.5
4.7
1.8
2.7
mu/l
0.61
164
1525
207
1914
2.14
2.30
19.3
14.7
80.9
78.7
umol/l
0.38
207
1914
69
500
1.55
2.28
3.9
2.8
1.2
0.5
e6/l
0.37
52
360
198
1807
1.85
2.25
5.2
4.8
5.8
6.0
mmol/l
1.05
161
1640
45
298
1.64
2.16
2.9
2.8
3.0
2.7
e6/l
0.10
24
152
9
31
2.98
2.09
1.9
1.3
—
—
—
0
0
16
76
2.19
2.08
1.4
1.9
1.1
1.5
g/l
0.89
11
65
9
32
2.89
2.02
1.2
1.3
—
—
—
0
0
83
641
1.47
1.99
4.4
2.9
—
—
—
0
0
189
1720
1.65
1.94
4.7
4.2
1.3
1.3
mmol/l
0.45
152
1561
204
1897
1.88
1.91
20.1
15.2
4.0
4.0
mmol/l
0.52
199
1834
8
28
2.92
1.88
2.0
1.3
—
—
—
0
0
50
353
1.54
1.83
3.3
2.1
2.5
2.4
mmol/l
1.87
43
305
5
12
4.24
1.83
1.8
1.3
—
—
—
0
0
18
96
1.95
1.76
3.3
1.6
2.2
5.6
ug/l
0.61
11
76
35
230
1.62
1.73
4.4
7.2
—
—
—
0
0
5
13
3.91
1.72
1.6
1.1
—
—
—
0
0
45
315
1.54
1.71
2.8
2.5
0.8
1.2
e6/l
0.60
24
168
11
49
2.31
1.66
2.1
3.8
—
—
—
0
0
5
14
3.63
1.62
2.4
1.2
—
—
—
0
0
5
14
3.63
1.62
1.4
1.1
—
—
—
0
0
63
478
1.44
1.62
3.4
2.4
6255.3
10723.8
umol/l
0.30
57
411
6
20
3.05
1.59
2.3
1.2
—
—
—
0
0
156
1388
1.41
1.56
5.4
3.8
15.1
14.9
pmol/l
0.38
130
1253
14
72
2.01
1.52
2.3
2.6
39.4
41.8
u/l
0.18
14
63
118
1006
1.37
1.51
2.9
2.8
—
—
—
0
0
40
281
1.52
1.50
2.0
1.7
—
—
—
0
0
74
588
1.39
1.45
2.7
2.0
297.5
176.4
u/l
0.60
66
549
52
392
1.43
1.37
3.0
1.7
0.9
1.1
mg/l
0.23
40
297
9
42
2.19
1.35
1.0
1.8
—
—
—
0
0
130
1139
1.34
1.33
4.0
2.9
50.9
45.2
u/l
0.37
117
1060
57
441
1.39
1.30
4.8
3.9
20.3
24.5
%
2.32
28
211
12
62
1.99
1.30
1.9
1.5
—
—
—
0
0
122
1062
1.33
1.29
4.2
3.8
6.5
6.7
mmol/l
0.47
117
986
18
108
1.73
1.26
1.7
1.7
—
—
—
0
0
11
56
2.01
1.24
1.9
1.5
—
—
—
0
0
20
125
1.66
1.22
13.6
6.6
14.3
10.6
mmol/l
0.67
20
118
7
33
2.16
1.06
1.3
1.3
—
—
—
0
0
7
33
2.16
1.06
1.3
1.3
—
—
—
0
0
9
46
2.00
1.05
1.7
1.2
—
—
—
0
0
9
47
1.95
1.03
1.7
1.4
—
—
—
0
0
9
49
1.87
1.00
1.0
1.6
—
—
—
0
0
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
26
185
1.46
0.94
3.3
3.0
—
—
—
0
0
32
238
1.40
0.93
1.8
1.4
—
—
—
0
0
61
502
1.30
0.92
1.5
1.6
1.3
1.3
mmol/l
0.02
46
419
36
275
1.37
0.90
3.9
1.6
32.1
29.3
s
1.51
36
262
41
321
1.34
0.88
1.4
1.3
23.5
36.1
iu/ml
0.57
11
95
68
572
1.27
0.87
5.9
4.0
11.4
2.0
ug/l
0.50
58
509
6
114
0.51
0.85
1.3
1.4
—
—
—
0
0
15
97
1.59
0.83
3.4
3.7
1.6
2.4
mmol/l
—
8
67
84
735
1.23
0.75
3.3
2.7
185.4
114.6
ug/l
1.29
74
674
7
38
1.87
0.74
1.0
1.1
—
—
—
0
0
53
443
1.26
0.71
2.6
2.1
2.9
3.1
mg/l
0.23
35
368
25
191
1.35
0.64
2.0
2.1
9.3
7.4
umol/l
0.17
19
162
12
79
1.55
0.64
7.8
7.3
26.4
24.8
mmol/l
0.46
12
71
6
38
1.59
0.54
1.0
1.2
3.9
3.9
mmol/l
—
6
33
11
74
1.51
0.54
1.4
1.2
—
—
—
0
0
24
188
1.31
0.54
4.9
5.6
2.6
1.6
mmol/l
0.41
18
148
15
110
1.39
0.50
1.4
1.5
—
—
—
0
0
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
44
386
1.17
0.38
5.2
4.0
248.4
235.2
ng/l
0.03
38
321
13
99
1.33
0.36
3.8
2.8
0.3
0.2
e6/l
0.23
13
94
6
42
1.44
0.36
1.8
1.6
15175.0
16009.3
e6/l
—
6
28
63
572
1.14
0.35
2.8
2.1
55.0
58.6
u/l
0.29
54
521
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
34
298
1.17
0.30
1.5
1.2
16.9
8.2
u/ml
0.28
11
101
43
476
0.88
0.28
5.4
3.9
0.0
0.0
estimate
0.00
24
146
24
206
1.18
0.27
1.9
1.7
—
—
—
0
0
64
689
0.90
0.26
4.3
3.8
—
—
—
0
0
13
105
1.25
0.25
1.7
1.9
—
—
—
0
0
58
536
1.11
0.25
3.2
2.4
29.0
32.8
u/l
0.81
53
506
0
11
0.00
0.21
0.0
2.4
—
49.5
—
0
6
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
73
772
0.92
0.20
3.1
3.7
20.8
40.7
ng/l
2.77
54
550
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
53
1.14
0.19
1.8
1.2
—
10.9
—
0
11
7
58
1.21
0.18
1.9
1.8
—
—
—
0
0
5
68
0.73
0.17
1.4
1.8
—
132.0
—
0
5
23
207
1.12
0.15
2.0
1.8
—
—
—
0
0
39
364
1.09
0.14
1.3
1.3
0.9
1.5
u/ml
0.49
13
102
91
882
1.05
0.11
4.1
3.7
0.0
0.0
estimate
0.00
24
152
12
135
0.88
0.10
3.1
1.9
41.5
58.9
ml/min/173m2
—
6
47
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
91
889
1.04
0.08
5.5
5.1
0.0
0.0
estimate
0.00
24
149
24
255
0.93
0.07
1.6
1.4
—
—
—
0
0
7
80
0.87
0.07
1.0
1.0
—
—
—
0
0
9
88
1.02
0.07
1.8
1.3
—
—
—
0
0
64
622
1.04
0.07
2.4
3.1
2108.7
1441.9
ng/l
0.42
54
524
13
120
1.09
0.05
2.0
2.0
—
—
—
0
0
21
200
1.06
0.04
6.2
5.0
102.8
104.3
mmol/l
0.57
21
195
13
138
0.94
0.02
7.2
5.1
1.4
1.4
mmol/l
0.00
13
131
91
900
1.02
0.02
4.0
3.8
0.0
0.0
estimate
0.00
26
145
41
417
0.98
0.01
1.9
1.8
428.5
437.1
pmol/l
0.06
26
335
16
166
0.96
0.00
2.3
3.1
6.5
5.8
kpa
0.99
16
159
13
127
1.03
0.00
1.7
1.7
—
—
—
0
0
17
167
1.02
0.00
2.2
3.1
2.5
2.2
mmol/l
0.12
12
133
40
397
1.01
0.00
2.1
1.7
1037.0
1238.8
nmol/l
0.76
24
295
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
2.6
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
0.4
—
0
6
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
9.9
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_UPPERLIMB_EXALLC – Melanoma in situ of upper limb, including shoulder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).